￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
028-123456789
Menu

Oncology

Is the KRAS inhibitor AMG510 in clinical trials in China

2025-10-19 11:44:20

Check Details
The world's first KRAS-targeting drug AMG-510 is launched

2025-10-19 11:44:20

Check Details
The emergence of AMG510 brings good news to patients with KRAS gene mutations!

2025-10-19 11:44:20

Check Details
Lumakras, the first KRAS-targeting drug for lung cancer, has been approved by the FDA - Kanghule

2025-10-19 11:44:20

Check Details
How effective is Amgen’s Lumakras treatment?

2025-10-19 11:44:20

Check Details
Price of Iressa in 2021, price of first-generation, second- and third-generation lung cancer targeted drugs

2025-10-19 11:44:20

Check Details
Iressa purchasing channels, lung cancer drug Iressa price

2025-10-19 11:44:20

Check Details
New lung cancer drugs are coming, Rybrevant is approved for marketing

2025-10-19 11:44:20

Check Details
What is the efficacy of EGFRex20ins + non-small cell lung cancer targeted drug RYBREVANT?

2025-10-19 11:44:20

Check Details
FDA approves FoundationOne CDx as companion diagnostic for brigatinib in the treatment of ALK+ metastatic NSCLC_Canghule

2025-10-19 11:44:20

Check Details
Does topotecan have any effect on small cell lung cancer

2025-10-19 11:44:20

Check Details
Which one of topotecan and irinotecan is more effective

2025-10-19 11:44:20

Check Details
Category
相关知识